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Breast cancer is the most common type of cancer among women worldwide. The number of
breast cancer survivors has been growing because of earlier detection and improved treat-
ment. Young women under 50 years of age account for relatively small percentage of all
newly diagnosed breast cancer patients. However, their medical and psychosocial context
of  the disease is unique. Breast cancer is diagnosed at the most productive time in life.
Concerns about childbearing, partner rejection, sexual function, body image, sexual attrac-
tiveness and career are common. For all these reasons experience of breast cancer diagnosis
and  treatment among young women requires special attention. Researches indicate that
oncological treatment may negatively affect female sexual functioning. Chemotherapy
is  one of the greatest risk factors of sexual dysfunctions, especially when it results in
medication-induced menopause. The duration and severity of sexual problems depend on
a  wide variety of factors: medical, psychological and interpersonal. These side effects may
last  for many years after the end of treatment. It is known that breast cancer affects both
patients and their partners. The ﬁrst sexual experience after surgery may be a turning point
in  sexual adaptation in couples. Communication is crucial in this process. More knowledge
about sexual difﬁculties and sexual adaptation process of young breast cancer survivors(YBCSs) and their partners is needed. Knowing protective and risk factors is necessary to
identify couples at risk for sexual dysfunctions in order to professionally support them in
the  best way and at the right time.
© 2013 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
breast cancer. Incidence rates have remained relatively sta-.  Introduction
reast cancer is the most common type of cancer in women in
he USA and both in the developed and developing countries
n Europe. Young women under 50 years of age account for
 relatively small percentage of all newly  diagnosed breast
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cancer patients. For example, in the USA women under the
age of 50 constitute approximately 24%,1 in the United King-
dom – 10%,2 in Poland – 18.2% of all women diagnosed withble over the past 20 years while mortality has decreased.
As a result, more  young women are becoming long-term
survivors.
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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Fig. 1 – The prevalence of sexual problems within 2–7194  reports of practical oncology an
Earlier diagnosis and advances in breast cancer treatment
have led to a growing number of breast cancer survivors. As
a result, the quality of life issues have become a matter of
great importance and particular attention has been paid to
sexuality.
2.  Aim
This study reviews the literature to present up-to date research
ﬁndings on sexual life among YBCSs. Firstly, from individ-
ual perspective, it describes side effects of every treatment
modality (surgery, radiotherapy, chemotherapy, and hormonal
therapy) on female sexuality and short-term and long-term
consequences from the very beginning to years after the end
of treatment. Secondly, dyadic perspective is used to show the
ways by which couples can cope with the challenges of the
disease.
Scientiﬁc articles were searched via the PubMed and Med-
line browsers and the web using the phrases: breast cancer,
young women,  premenopausal,  sexual,  and sexual functioning.  Ref-
erences given in the articles were also used.
3.  Younger  women  –  the  unique  experience
The experience of breast cancer diagnosis and treatment in
young women requires special attention because of the unique
medical and psychosocial context of the disease.
Younger women are diagnosed at more  advanced stages
than older women.3 Early detection is much more  difﬁcult
than in postmenopausal women because younger population
is not screened as rigorously as the older one and because
of lower sensitivity of mammography due to greater breast
density in this population. Breast cancer is more  likely to be
estrogen-receptor-negative, poorly differentiated with lypho-
vascular invasion.4 They have poorer 5-year prognosis and
receive more  aggressive treatment. Breast conserving surgery,
highly desirable, is associated with increased risk for local
recurrence in women under age of 35, while young patients
treated with mastectomy have a similar recurrence rate as
older ones.3,4
What is more,  young women are in a development period of
the highest productivity, when partners are chosen, families
settled, careers started and professional aspirations fulﬁlled.
Young adulthood is a particular time when sexual activ-
ity is an important aspect of life. Facing up breast cancer
diagnosis and treatment, young women have to cope with
multiple role demands as a partner, a mother, an employee
and the demands of a life-threatening illness. It is noteworthy
to mention that women under the age 50 are mostly pre-
menopausal, married or in committed relationships, many
have children at home and many  continue childbearing, with
higher percentage of single women and women without chil-
dren in comparison to older women.5 This unique context
creates special vulnerability. As a result, Young Breast Cancer
Survivors (YBCSs) have poorer quality of life and emotional
well-being, higher rates of depressive symptoms, more dis-
ruptions in body image,  more  difﬁculties in relationship,
especially in communication, they experience concerns aboutmonths after breast cancer diagnosis.6
fertility, premature menopause and higher rate of sexual prob-
lems than older BCSs.
Numerous studies report that diagnosis and breast cancer
treatment may have a detrimental effect on female sexual
functioning. In Fobair’s study,6 about half of women  experi-
enced severe or moderate sexual problems in early months
after diagnosis. These data show the magnitude of the prob-
lem (Fig. 1). In addition, the sexual sphere for young women
seems to be indispensable to fulﬁll their developmental tasks.
4.  Female  sexuality  –  M.  Basson’s  model
Neither the linear model proponed by Masters&Johnson, nor
Kaplan’s model is adequate to describe female sexuality. Both
of them stress the importance of vaginal reactions and ﬁt well
with male sexual response. Nowadays, we know that female
sexual response is highly individual and contextual with the
overlapping phases and the circular model is the most appro-
priate to capture the true essence of female sexual experience
(Fig. 2).7
Female sexual functioning depends on many  factors: med-
ical, psychological, interpersonal and sociocultural. They play
an important role in the occurrence and severity of sexual
dysfunctions (Table 1).
In the context of breast cancer treatment, a lower level of
sex hormones and alteration in body image, poor emotional-
wellbeing, and low quality of relationship with a partner
may decrease libido, affect subjective arousal and lubrication
leading to painful intercourses and anorgasmia. The loss of
sexual satisfaction due to pain and disappointment remark-
ably reduces sexual activity and the quality of relationship
both in the affected women and her partner.
5.  Sexual  functioning  versus  treatment
modalities
5.1.  Surgery
The loss or deformation of a breast as a result of mastectomy
or breast reconstructive surgery can evoke a lot of negative
feelings regarding body image.8 It could be especially difﬁcult
for younger women because of their youth and high social and
cultural expectations of physical beauty. Although the type
of surgery – mastectomy versus breast-conserving surgery
– has no direct impact on sexual functioning, altered body
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mage  may be a mediating factor.9,10 When different aspects
f sexual functioning were considered, breast reconstructive
urgery resulted in fewer problems with sexual interest, but no
ifference was reported in sexual dysfunctions.11,12 The loss
f breast sensitivity can lead to modiﬁcations in foreplay. The
ore  breast caressing is important for couple’s foreplay the
reater disruptions in sexual life may occur.
.2.  Chemotherapy  (CTH)
hemotherapy can cause a wide variety of side effects which
irectly or indirectly affect female sexuality (Fig. 3), especially
5,13f it results in a premature menopause.
The impact of CTH on menopausal status appears to be
ne of the most important factors. Ochsenkuhn’s study14
hed light on the mediating role of menopause, while
Table 1 – Complexity of factors related to sexual functioning in
Medical and biological Psychological/intrape
• Breast cancer treatment modality
(surgery, radiation therapy,
hormonotherapy, chemotherapy) and
its side effects
•  Prior sexual experiences 
• Menopausal status • Emotional well-being (dep
anxiety)
• Antidepressants • Negative expectations rega
sexual interactions
• Drugs • Body image 
• Age • Self-esteem 
• Fatigue • Sense of feminity 
• Level of stability of identit
of breast as a an element of
identityesponse cycle.7
chemotherapy itself did not signiﬁcantly affect sexual desire,
unless permanent menopause was induced. The abrupt onset
of menopause induced by chemotherapy is a great source of
stress for young women, because attendant symptoms: hot
ﬂashes, night sweats, mood swings, cognitive changes, sleep
disturbances, joint pain, low sexual desire and vaginal dry-
ness are at more  severe level than when they occur in natural
process of gradual menopause. It is known that a substan-
tial percentage of YBCSs experience bothersome menopausal
symptoms.15 Menopause is also unexpected at this stage in
life and many  women are not prepared for such a change.
In addition, chemotherapy in a reproductive age is related
with concerns about future childbearing. This treatment
can cause follicular damage with preservation of menses,
temporary amenorrhea, irregular menses or irreversible
amenorrhea.16 Fertility after chemotherapy strongly depends
 BCSs.
rsonal Interpersonal/relationship Sociocultural
• The quality of relationship
with the partner
•  Social norms
ression, •  Social support from partner • Cultural values
rding •  Attractiveness of women
breast cancer treatment for her
partner and vice versa
• Stereotypes
• Communication (especially
the degree to which sexual
issues were discussed within
relationship)
•
Discriminations
• Prior sexual life with the
partner
Religious beliefs
• The importance of sex for
quality of relationship
y; the role
 female
•  The importance of breast as a
part of a foreplay
• Partners’ sexual problems
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on women’s age. The probability that women  will enter
menopause dramatically increases over the age of 35.5
Younger women can tolerate high doses of chemotherapy
longer than older ones, for example women under 40 develop
amenorrhea in 4–8 months compared to women over 40 who
can develop amenorrhea in 2–4 months.16 Infertility causes
a sexual act to be only able to meet psychological needs for
pleasure and interpersonal needs for closeness and intimacy
while biological needs for procreation cannot be fulﬁlled.
5.3.  Radiotherapy  (RTH)
Consequences of radiotherapy are mostly local and tempo-
rary and are generally limited to pain and irritations of the
breast skin. In some cases severe side effects, as chronic ﬁbro-
sis, may limit physical positioning during a sexual intercourse.
The pattern of sexual adjustment was shown in a longitudinal
study by Dow and Lafferty17 Data were collected at four time
points: T1 – the ﬁrst week of RTH (baseline), T2 – the third
week of RTH (midpoint) when side effects like skin reactions
and fatigue occur, T3 – the ﬁfth week of RTH when side effects
are most troublesome, T4 – six months after beginning of RTH.
Sexual adjustment decreases from the beginning till the end
of treatment which corresponds to the growing severity of side
effects with its peak at the end of RTH, and improves to near
baseline levels six months later (Fig. 5).
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5.4.  Endocrine  therapy  (ETH)
As far as endocrine therapy is concerned, sexual function-
ing outcomes are mixed, with some suggesting no effect
on sexuality.16 ETH is frequently associated with abrupt
menopause; however, not consistently associated with sex-
ual problems.11 Tamoxifen can lead to increased vaginal
dryness.9 Fig. 4 shows different impacts of tamoxifen which
are dependent on menopausal status. In postmenopausal
women tamoxifen has a weak estrogenic effect, but in pre-
menopausal women it has a stronger estrogenic effect on
vaginal and uterine epithelium and can lead to increased vagi-
nal dryness and abnormal uterine bleeding.9
6.  Consequences  of  breast  cancer  treatment
There is another trend in research on sexuality of BCSs which
distinguishes short-term consequences of breast cancer treat-
ment from long-term ones.
6.1.  Short-term
In general, sexual activity decreases in young women with
breast cancer during 1 year after surgery.18 In a prospective
study conducted by Burwell et al.,19 more  sexual prob-
lems were experienced immediately after surgery and the
end of treatment. Although problems diminish over time,
some women still report problem 1 year after surgery
(Fig. 6). Chemotherapy itself has short-term effect on sexual
4
5
6
7
8
9
0
1
2
t1 t2 t3 t4
sexal 
adjustment
Fig. 5 – Sexual adjustment during radiotherapy.17 Lower
scores indicate higher sexual adjustment.
reports of practical oncology and radiotherapy 1 8 ( 2 0 1 3 ) 193–200 197
0
5
10
15
20
25
30
35
40
45
prediagnosis after surgery 6th month 12th month
sexual interest arousal relaxation orgasm dissatisfaction
F
f
w
e
i
i
a
d
i
T
i
t
6
S
p
F
t
Y
m
s
t
t
h
5
q
s
n
Fig. 7 – Sexual functioning among sexually active YBCSs 5
ig. 6 – Sexual problems within 12 months after surgery.19
unctioning; however, disruptions in sexuality are long-term
hen CHT leads to menopausal transition.19 The devastating
ffect of premature menopause in young women was shown
n Ochsenkuhn research14 which claims that sexual function-
ng was most impaired for women no longer menstruating
fter chemotherapy. Sexual interest was the most problematic
omain.6,19 Romantic stimuli are much more  effective in evok-
ng sexual activity than erotic ones according to Biglia et al.18
here is also evidence that women are much more  interested
n nonsexual, affectionate behaviour like: hand holding, sit-
ing close, and embracing than in sexual act itself.20
.2.  Long-term  consequences
exual dysfunction and diminished sexual satisfaction can
ersist for more  than a year and may increase over time.9
ive years after surgery, sexual activity and difﬁculties in
his area have not signiﬁcantly changed in the group of 185
BCSs (Fig. 7); nearly three fourths of the women were pre-
enopausal and a lot of them experienced hot ﬂashes, night
weats and vaginal dryness.21 Most probable explanation is
hat at the beginning sexual problems are mostly caused by
reatment, 5 years later, by menopause.
Women with menopause permanently induced by CHT
ave impaired sexual desire 2–8 years after surgery.14 From
 to 10 years following diagnosis vaginal dryness, reduced fre-
uency of sexual activity and reduced breast sensitivity were
till experienced, but impaired sexual desire and dyspareu-
ia were not common.22 An interesting research conducted to
Fig. 8 – The sexual dysfunctions model in years after surgery.21
compare sexual functioning between 10-year BCSs and 5-year
BCSs showed a decline in sexual activity (62% vs. 71%) and
a lower rate of reported sexual problems due to cancer (19%
vs. 27%).1 However, there were no impairments of the sexual
domain of quality of life 10 years after surgery.23 In a study
conducted by Alder et al.,10 68% of BCSs reported sexual dys-
functions a few years after surgery which was much higher
a percentage than among healthy women. The only signiﬁ-
cant predictor for sexual desire was quality of relationship,
rather than androgen level which is supposed to be associated
with sexual interest. Chemotherapy was predictive for difﬁcul-
ties with arousal, lubrication, orgasm and sexual pain. These
results ﬁt well with the model for female sexual response pro-
posed by Basson.24–28
To sum up: ﬁrstly, sexual problems may persist and worsen
with time and aging. Nowadays, it is difﬁcult to answer
whether these changes 1, 5 and 10 years1,21 after the end of
treatment can be attributed to the late effects of treatment or
the normal effects of aging. There is a need to compare ﬁnd-
ings with same-age control group. Secondly, female sexuality
is affected for a long time both by persistent side effects of
treatment and quality of relationship with a partner.
7.  First  sexual  experience  after  surgery  as
a turning  point  of  couple’s  sexual  adjustmentSexual functioning is particularly relevant to a couple relation-
ship and may be disrupted by breast cancer treatment. Sexual
couple after breast cancer treatment.5
198  reports of practical oncology and rad
Table 2 – Many  factors have an impact on women’s
sexual adjustment.5,20,29
Factors important to women’s sexual adjustment
• The quality of the ﬁrst sexual experience after surgery20
• How frequent partner initiates sexual activity20; if the partner
initiates sex women are able to become aroused and enjoy sexual
act although some of them do not feel sexual desire and do not
initiate sexual contact29
• Perceptions of partner positive emotional involvement in the
relationship20
• The females’ perceptions of their male partners’ reaction to
breast cancer diagnosis20
• Communication about sex within relationship
•Prior sexual life
• The quality of couple relationship
• The importance of breasts in the foreplay
a great source of stress for a young single women. In their• Partner initial reaction on naked BCSs29
problems occur with great frequency. They depend on many
factors that have an impact on the outcomes of the ﬁrst sexual
experience after surgery (Table 2).
Breast cancer diagnosis affects a woman, her partner and
the couple’s life. The context of disease and treatment is highly
stressful. The couple must face a wide range of changes: phys-
ical and physiological, intrapersonal and interpersonal. As a
consequence, both partners suffer more  emotional distress.
It is worth to pay attention to partners’ distress. Male part-
ners of young women can be overwhelmed with multiple
and competing demands. They provide women with emo-
tional support and at the same time they deal with their own
distress, respond to children needs, support the family who
are mostly unaware or uninformed how to best assist the
patient.
The relationship with the partner is essential in women’s
adaptation to illness. In most cases in western culture part-
ners are supportive. However, for some couples breast cancer
can bring previous problems under magniﬁcation or for some
women it may become an impetus to end unsatisfying rela-
tionships. In a study conducted by Walsh et al.,30 75% of
partners strengthened their bond, felt increased closeness and
intimacy and 17% of patients acknowledged appreciating their
partner more.  But 25% of respondents reported increased rela-
tional strain which was mostly related with communication
avoidance and in 12% of cases ended up in separation or ter-
mination of relationship. Nearly 70% of couples experienced
sexual problems.
A lot of fears are related to sexuality, for instance female
concerns about her partner’s reaction to breast cancer itself,
disﬁgurement of the body, fears of rejection, and male con-
cerns about any changes in woman’s body (if they would be
acceptable for him), loss of a partner or recurrence, how to
avoid hurting the partner during a sexual intercourse, about
caressing insensitive breast. Marshall and Kiemle’s29 qualita-
tive study on the impact of breast reconstruction following
cancer on patients’ and partners’ sexual functioning shed
some light on the experience of partners who must adapt to
a new situation. Anxiety about damaging the reconstructed
breast, pain while touching or doing something wrong when
being intimate may have an impact on their desire and
arousal. Changes in touching and caressing due to insensitiveiotherapy 1 8 ( 2 0 1 3 ) 193–200
breast, longer time to arouse the wife are great challenges for
partners, even though initially the majority of men  found their
partner’s survival as a priority rather than sexual concerns.29
What is more,  not only women but also their partners may
experience difﬁculties with arousal when their worries dis-
tract them from sexual pleasure. Consequently, they may feel
embarrassed.
In some cases, a role change within the caring process
from symmetric relationships between partners to asym-
metric relationship between a caregiver and a dependant
caretaker invalidates the sexual aspect of interactions. Con-
sequently, sexual attractiveness and desire disappear with
partner’s feeling more  like a caregiver than a lover.
For all these reasons, the ﬁrst sexual act after surgery may
be a turning point in sexual adaptation. Apart from medical
factors, psychological ones disrupt sexual functioning. Both
the man  and the woman  during a sexual act focus more  on
their worries than on pleasure of erotic sensations and emo-
tional intimacy which decreases arousal to such an extent
that it prevents the development of a sexual response and
makes genital intercourse impossible. As a result, both part-
ners are left at ﬁrst with the sense of failure and when this
situation becomes repeatable – with anticipations of pain and
discomfort related to sexual performance. When combined
with communication difﬁculties and protective buffering, that
is the avoidance of discussion of every single concern in order
to protect the other person, it may lead to a stable pattern of
sexual avoidance and withdrawal, especially if reinforced by
the decrease in anxiety. Undoubtedly, open communication
with the partner, sharing feelings about cancer related issues
and sexual needs and expectations are essential to achieve a
better sexual satisfaction (Fig. 8).
According to Baucom et al.,5 younger women experience a
particularly high rate of sexual difﬁculties which do not appear
to be a short-term problem and communication concerns are
the most problematic relationship difﬁculty.12,30,31 It is known
that an overall good marital relationship is not sufﬁcient for
sexual adaptation. Certain types of interactions are crucial5:
• candid communication about cancer-related issues,
• the ability to express emotions and to have one’s partner
listen supportively,
• effective problem solving skills,
• high level of empathy from spouses,
• the more  male partners disclose (sharing his feelings and
thoughts about cancer), the more  intimate women felt,
• partner immediate response to cancer-related topic with
their own disclosure or with humor was more  helpful than
unsolicited task oriented or intellectual response.
8.  Single  women  as  a  risk  group
Single women have generally more  worries about their sexual
attractiveness and are more  likely to feel embarrassed than
partnered women.6 Seeking new dating relationship can besearch for a partner and in a new relationship she faces mul-
tiple problems: feeling less desirable for a potential mate can
be an obstacle in meeting someone, an important issue could
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e the best time and the best way to divulge anatomic changes
f the body. She may worry about her partner’s reaction to her
aked and deformed breast and the fact that she is a breast
ancer survivor and as a result avoid taking part in any sort
f sexual relationship. Concerns about dating are relatively
igh.12 All these fears, when not confronted with reality, have
 tendency to maintain and intensify. For this reasons single
omen may need more  support than partnered ones.
.  Conclusions
n general, research about women’s cancer-related sexual dys-
unctions and their treatment has lagged behind that for men
nd YBCSs’s sexuality is still an overlooked issue. For exam-
le, sexual functioning in testicular cancer survivors is a far
etter-examined area of research than in YBCSs, even though
esticular cancer is relatively rarely diagnosed.32 Although
reast cancer affects both patients and their partners, little
s known about the partners’ perspective and relationships in
ouples. More  research on sexual functioning in heterosexual
nd same-sex couples in the cultural context is needed with
ore attention paid to a good methodological background.
any studies are limited due to the lack of control groups
nd the use of unstandardised instruments for measuring
exual functioning. What is more,  ﬁndings are difﬁcult to com-
are because of the differences in the deﬁnitions of ‘young’ as
omen under 50, or under 45, 40, or 35. Also, different ques-
ionnaires are used, various aspects of sexuality are examined,
nd even theoretical models of sexuality differ from one study
o another. For all these reasons, results of studies should be
pproached with a lot of caution. The current evidence-based
odel of female sexual response should be used as a theoret-
cal framework and recommendations for new deﬁnitions of
exual dysfunctions in assessment and treatment should be
aken into account in future studies.
Research shows that there is a need to develop methods to
elp women deal with premature menopause and attendant
enopausal symptoms. Understanding the impact that breast
ancer diagnosis and its treatment have on sexual function-
ng in young women and their partners during treatment and
ecovery period, it is necessary: primarily to provide both part-
ers with adequate information and discuss important sexual
ssues at every stage of treatment and recovery, and sec-
ndly, to identify couples at risk for sexual dysfunctions and
ffer them professional and adequate help at the right time.
owadays, age-related and couple-based psychoeducational
nterventions with an element of sexual therapy interventions
eem to be the most beneﬁcial treatment modality.33
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